---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-072809"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2026-11-10T21:46:21+00:00"
generated_at: "2026-11-10T21:47:04.578089+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# Azenta FY26 revenue $622M, up 5%; GAAP EPS -$3.50 on $149M impairment; FY27 revenue guided $648-660M

## Summary
- Q4 revenue $167M, +5% YoY (+2% organic); Sample Management Solutions $94M (+9%), Multiomics $73M flat; adjusted diluted EPS $0.28 vs $0.21 a year ago.
- FY26 GAAP operating loss $174.7M and continuing-ops diluted EPS of -$3.50, including a $149M non-cash goodwill impairment; adjusted EPS $0.48 vs $0.51.
- FY27 outlook: revenue $648-660M, organic growth 3-5%, adjusted EBITDA margin up 200-250 bps including 100 bps dilution from Elegen and SynPlexity; FCF up ~25%.
- Acquired SynPlexity Oct 28 for $15M cash ($2.5M holdback) plus up to $10M contingent; Elegen license carries $23M fixed payments and a $25M perpetual conversion option.
- B Medical Systems sold July 1, 2026, with the $35M vendor loan repaid Sept 3; FY26 repurchases totaled 4.4M shares for $118.2M, $131.8M left on the $250M program.

## SEC filing metadata
- accession: 0001628280-26-072809
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2026-11-10T21:46:21+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000162828026072809/0001628280-26-072809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000162828026072809/azta-20261110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-072809
- JSON: https://secwatch.observer/filing/0001628280-26-072809.json
- Plain text: https://secwatch.observer/filing/0001628280-26-072809.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.